Completed OBSERVATIONAL NCT06908005
RaFIST: A Radiomics-Based Tool for Intratumoral Fibrosis Stratification in Non-Small Cell Lung Cancer
Development and Prognostic Validation of RaFIST: A Radiomics-Based Tool for Intratumoral Fibrosis Stratification in Non-Small Cell Lung Cancer
Sponsor: Jinling Hospital, China
Conditions
Lung Cancer - Non Small Cell
Interventions
CT radiomic analysis Fibrosis assessment
Updated 1 time since 2025 Last updated: Apr 6, 2025 Started: Apr 1, 2024 Primary completion: Dec 1, 2024 Completion: Mar 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Lung Cancer - Non Small Cell, this trial is completed. The trial is conducted by Jinling Hospital, China and has accumulated 1 data snapshot since 2024. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Jinling Hospital, China
Data source: Jinling Hospital, China
For direct contact, visit the study record on ClinicalTrials.gov .